Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS

Everolimus-eluting bioresorbable scaffolds and metallic stents in diabetic patients: a patient-level pooled analysis of the prospective ABSORB DM Benelux Study, TWENTE and DUTCH PEERS

Abstract Background Several studies compared everolimus-eluting bioresorbable scaffolds (EE-BRS) with everolimus-eluting stents (EES), but only few assessed these devices in patients with diabetes mellitus. Aim To evaluate the safety and efficacy outcomes of all-comer patients with diabetes mellitus...

Full description

Bibliographic Details
Main Authors: T. M. Hommels, R. S. Hermanides, B. Berta, E. Fabris, G. De Luca, E. H. Ploumen, C. von Birgelen, E. Kedhi
Format: Article
Language:English
Published: BMC 2020-10-01
Series:Cardiovascular Diabetology
Subjects:
Bioresorbable scaffolds
Drug-eluting stents
Diabetes mellitus
Coronary artery disease
Percutaneous coronary intervention
Device thrombosis
Online Access:http://link.springer.com/article/10.1186/s12933-020-01116-2

Similar Items

Similar Items